BBVA
GMAB icon

Banco Bilbao Vizcaya Argentaria’s Genmab GMAB Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,180
Closed -$223K – 740
2025
Q4 		$223K Buy
+7,180
New +$224K ﹤0.01% 697

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's GMAB Position: Q1 2026 in Review

Banco Bilbao Vizcaya Argentaria sold out of Genmab (GMAB) in Q1 2026, closing a stake of 7,180 shares — an estimated $223K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in GMAB in Q4 2025 and held it in 1 quarter. The position peaked at $223K in Q4 2025. 273 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 7,180 Genmab shares in Q1 2026, an estimated $223K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Genmab in Q4 2025 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Genmab position peaked at $223K in Q4 2025.
  • 273 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q1 2026, filed 14 May 2026.